InvestorsHub Logo
Followers 65
Posts 3380
Boards Moderated 0
Alias Born 08/22/2012

Re: TheDane post# 51190

Tuesday, 01/14/2014 8:30:46 AM

Tuesday, January 14, 2014 8:30:46 AM

Post# of 403168
i predict the stock will rise on material news... not conference presentations...

Brilacidin ABSSSI p2b initiation and dosing of first patient
Brilacidin OM p2 filing of IND
Prurisol p1 filing of IND
Brilacidin OM p2 initiation of trial and dosing of first patient
Prurisol p1 initiation of trial and dosing of first patient
Prurisol p1 findings which allow CTIX to move forward w/ p2
Prurisol p2/3 initiation and dosing of first patient
Kevetrin p1 at DF data/findings related to efficacy
Kevetrin initiation of Bologna trial and dosing of 1st patient
Award of SPORE grant to BI for Kevetrin trial
FDA awarding Brilacidin OM orphan drug status
FDA awarding Brilacidina ABSSSI or Kevetrin fast track or breakthrough status
Partnership with big pharma with significant upfront payment, milestone payments and back end royalties providing cash
Positive clinical trial data for any of the clinical trials...

This is what will move the stock price upward... this is what will cause the market to re-evaluate CTIX and increase its market cap... these are the fundamentals of this investment space... glta
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News